DNA Exome Sequencing TCM for Sjögren's Syndrome

Using the DNA Exome Sequencing Tools to Explore the Association Among Gene Sequence, TCM Pattern, TCM Tongue Diagnosis and TCM Pulse Diagnosis for Sjögren's Syndrome

To explore the association among gene, TCM pattern, TCM tongue diagnosis and TCM pulse diagnosis with the DNA Exome sequencing tools for Sjögren's syndrome

Objective: To explore the association among gene, TCM pattern, TCM tongue diagnosis and TCM pulse diagnosis with the DNA Exome sequencing tools for Sjögren's syndrome

Method:

This study wants to establish the reference value of DNA gene variants of healthy control for comparing with the Sjögren's syndrome subjects. And the investigators want to use the DNA Exome sequencing tools, proteomics and oral microbiome to explore the association of gene expression between at least 30 Sjögren's syndrome subjects and at least 10 healthy control subjects. Finally, the investigators also analyze the association among gene expression, proteomics and oral microbiome, TCM pattern, TCM tongue diagnosis, TCM pulse diagnosis, and heart rate variability (HRV) for this purpose.

Expected Results:

1. To evaluate the difference among TCM pattern, TCM tongue diagnosis, TCM pulse diagnosis, and HRV for the Sjögren's syndrome and healthy control.
2. To evaluate the immunity-related gene expression for the Sjögren's syndrome and healthy control.
3. To evaluate the proteomics for the Sjögren's syndrome and healthy control.
4. To evaluate the oral microbiome for the Sjögren's syndrome and healthy control.
5. To evaluate the association among the immunity-related gene expression, SSA, SSB and RF.

Keyword: Sjögren's syndrome, Immune regulation, Gene modulation, TCM pattern, TCM tongue diagnosis, TCM pulse diagnosis, proteomics, oral microbiome

Sjögren's syndrome

Inclusion Criteria:

• (1) primary or secondary SS
• (2) aged between 20 and 75 years
• (3) fulfilled the 2002 American-European Consensus Criteria for SS (AECG)
• (4) had no abnormal findings of immune, liver, kidney, or blood function evaluations.

Exclusion Criteria:

• (1)a history of alcohol abuse, diabetes mellitus, or major life-threatening condition
• (2) pregnancy or breastfeeding
• (3) steroid pulse therapy within three months prior to the commencement of our study.

Health Subjects

Inclusion Criteria:

• (1) aged 20 and 75 years
• (2) had no chronic inflammatory illness.

Exclusion Criteria:

• (1) a history of alcohol abuse, diabetes mellitus, or major life-threatening condition
• (2) pregnancy or breastfeeding
• (3) abnormal findings of immune, liver, kidney, or blood function evaluations
• (4) total sleeping time insufficiency less than 6 hours before one day of enrollment
• (5) ever took the conventional medicine or hormone within one month
• (6) ever encountered the acute illness, allergy reaction, immune, or rheumatic disease within one month.